Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02412696 · ClinicalTrials.gov registry record · NA
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)
A NA study of Obesity and Pregnancy, sponsored by The Miriam Hospital.
- Active
- Registry status
- NA
- Development phase
- 262
- Enrollment target
- 1
- Study location
NCT02412696: Active NA study of Obesity and Pregnancy, sponsored by The Miriam Hospital.
NCT02412696 is a NA study of Obesity and Pregnancy that is active but no longer recruiting, run by The Miriam Hospital. The registered enrollment target is 262 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02412696, a NA study of Obesity and Pregnancy, is active but no longer recruiting, sponsored by The Miriam Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing the hypothesis of whether continuous positive airway pressure (CPAP) therapy improves placental histopathology and secretory function. The main aims of the study are to identify shared mechanisms between obstructive sleep apnea and preeclampsia, both common highly morbid conditions.
Primary Outcome
Placenta secreted markers that have been linked to preeclampsia as well as angiogenic and anti-angiogenic markers will be measured longitudinally during the course of pregnancy.
Conditions Studied
Interventions
- DEVICE Positive Airway Pressure
- OTHER Nasal Dilator Strips
Study Locations (1)
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What the registry record for NCT02412696 still lists
NCT02412696 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower).
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Positive Airway Pressure is the first listed.
NCT02412696 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02412696 about?
NCT02412696 is a clinical study titled "Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)". This study is testing the hypothesis of whether continuous positive airway pressure (CPAP) therapy improves placental histopathology and secretory function. The main aims of the study are to identify shared mechanisms between obstructive sleep apnea and preeclampsia, both common highly morbid condit...
What is the current status of trial NCT02412696?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 262 participants. The study started on 2015-06-01. Estimated completion is 2025-05-01.
What conditions does trial NCT02412696 study?
This clinical trial studies the following conditions: Obesity, Pregnancy, Obstructive Sleep Apnea, Sleep, Preeclampsia.
What interventions are being tested in trial NCT02412696?
The interventions under investigation include: Positive Airway Pressure (DEVICE), Nasal Dilator Strips (OTHER).
Who is sponsoring clinical trial NCT02412696?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02412696 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02412696's enrollment target sits among peer trials
262 248th of 1053 higher than 806 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI